Copertina

Osteopontin deletion attenuates cyst growth but exacerbates fibrosis in mice with cystic kidney disease

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Kyle P. Jansson, Jordan Kuluva, Shiqin Zhang, Taylor Swanson, Yan Zhang, Kurt A. Zimmerman, Timothy A. Fields, Darren P. Wallace, Peter S. Rowe, Jason R. Stubbs
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Physiological Reports
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Cardiac fibrosis induced by high‐fat diet in ApoE ‐deficient male mice is exacerbated by genetic deletion of PACAP – PAC1 signaling
di: J. M. Schubart, et al.
Pubblicazione: (2025)

Lung function outcomes of cystic fibrosis patients after early‐life pulmonary exacerbations: National registry analysis
di: Satı Özkan Tabakçı, et al.
Pubblicazione: (2026)

The foregut in cystic fibrosis
di: Christopher Vélez, et al.
Pubblicazione: (2024)

Increased exacerbations of bronchiectasis following recovery from mild COVID‐19 in patients with non‐cystic fibrosis bronchiectasis
di: Wang Chun Kwok, et al.
Pubblicazione: (2024)

The BEAT-CF Causal Model: A model for guiding the design of trials and observational analyses of cystic fibrosis exacerbations
di: Mascaro, Steven, et al.
Pubblicazione: (2025)

Time to be blunt: Substance use in cystic fibrosis
di: Sanaz Vaziri, et al.
Pubblicazione: (2024)

New advances in the therapy of non-cystic fibrosis bronchiectasis
di: A. Amorim
Pubblicazione: (2013)

Respiratory sleep disturbance in children and adolescents with cystic fibrosis
di: A. M. Silva
Pubblicazione: (2016)

Disparities in elexacaftor/tezacaftor/ivacaftor initiation in the US cystic fibrosis population
di: Kamyron Jordan, et al.
Pubblicazione: (2024)

Prevalence of cannabidiol use in persons with cystic fibrosis
di: Emma M. Tillman, et al.
Pubblicazione: (2024)

El empleo de trabajadores inválidos en la industria
di: Kurt Jansson
Pubblicazione: (1953)

The employment of handicapped workers in industry
di: Kurt Jansson
Pubblicazione: (1953)

L'emploi des invalides dans l'industrie
di: Kurt Jansson
Pubblicazione: (1953)

Germline deletion of Rgs2 and/or Rgs5 in male mice does not exacerbate left ventricular remodeling induced by subchronic isoproterenol infusion
di: Shelby Dahlen, et al.
Pubblicazione: (2025)

The equitable challenges to quality use of modulators for cystic fibrosis in Australia
di: Laura K Fawcett, et al.
Pubblicazione: (2024)

Interruption of intermittent hypoxia attenuates the severity of pulmonary fibrosis in male mice
di: Zakaria Maakoul, et al.
Pubblicazione: (2025)

The future of cystic fibrosis: A global perspective
di: Felix Ratjen
Pubblicazione: (2024)

Narratives of the parents’ experience of children with cystic fibrosis
di: Selene Beviláqua Chaves Afonso
Pubblicazione: (2015)

Prevalence and treatment of iron deficiency in children with cystic fibrosis
di: Anna Twomey, et al.
Pubblicazione: (2025)

Using the internet to exchange information and experience on cystic fibrosis
di: Ellen Dayane Cargnin Pimentel
Pubblicazione: (2013)

The impact of Asic2 deletion on metabolic homeostasis in mice
di: Madison Hamby, et al.
Pubblicazione: (2025)

Inducible deletion of endothelial cell Efnb2 delays capillary regeneration and attenuates myofibre reinnervation following myotoxin injury in mice
di: Aaron B. Morton, et al.
Pubblicazione: (2024)

Clinical evidence of pancreatic recovery in children with cystic fibrosis on ivacaftor
di: Sydney Walker, et al.
Pubblicazione: (2024)

Nutrition and behavioral health in cystic fibrosis: Eating and body image
di: Emma R. Lyons, et al.
Pubblicazione: (2024)

Challenges to assessing the true burden of iron deficiency in cystic fibrosis
di: Bailey V. Hamner, et al.
Pubblicazione: (2025)

Towards personalized medicine for cystic fibrosis patients with rare mutations
di: László Csanády
Pubblicazione: (2024)

Impact of sociodemographic status and sex on chronic rhinosinusitis and olfaction in people with cystic fibrosis
di: Ethan J. Han, et al.
Pubblicazione: (2024)

Contemporary outcomes of isolated liver and combined liver‐lung transplantation for cystic fibrosis in children
di: Ioannis A. Ziogas, et al.
Pubblicazione: (2026)

Effects on growth, weight and body composition after CFTR modulators in children with cystic fibrosis
di: CM. López Cárdenes, et al.
Pubblicazione: (2024)

Physical performance, quality of life and sexual satisfaction evaluation in adults with cystic fibrosis: An unexplored correlation
di: K.C.A. Aguiar
Pubblicazione: (2017)

MOR23 deficiency exacerbates hepatic steatosis in mice
di: Wesuk Kang, et al.
Pubblicazione: (2024)

Comparison of 3D UTE free‐breathing lung MRI with hyperpolarized 129Xe MRI in pediatric cystic fibrosis
di: Samal Munidasa, et al.
Pubblicazione: (2024)

Physiologically‐based pharmacokinetic modeling of the drug–drug interaction between ivacaftor and lefamulin in cystic fibrosis patients
di: Magali Amiel, et al.
Pubblicazione: (2024)

Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy
di: Daniel P. Cook, et al.
Pubblicazione: (2024)

Lung T1 MRI assessments in children with mild cystic fibrosis lung disease
di: Clement L. Ren, et al.
Pubblicazione: (2024)

Pulmonary function, functional capacity and quality of life in adults with cystic fibrosis
di: V.J. Ribeiro Moco
Pubblicazione: (2015)

Adults with cystic fibrosis in Portugal: A first step towards improvement
di: T.H. Raja
Pubblicazione: (2016)

Evolution of nutritional management in children with cystic fibrosis – a narrative review
di: Chris Smith, et al.
Pubblicazione: (2024)

Close monitoring and early intervention: management principles for cystic fibrosis in Denmark
di: Tavs Qvist, et al.
Pubblicazione: (2024)

Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era
di: Kay Vavrina, et al.
Pubblicazione: (2025)